MPWT
WST icon

MassMutual Private Wealth & Trust’s West Pharmaceutical WST Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
342
+26
+8% +$7.95K ﹤0.01% 543
2026
Q1 		$79.2K Sell
316
-18
-5% -$4.48K ﹤0.01% 629
2025
Q4 		$91.9K Buy
334
+8
+2% +$2.19K ﹤0.01% 611
2025
Q3 		$85.5K Buy
326
+8
+3% +$1.94K ﹤0.01% 643
2025
Q2 		$69.6K Buy
318
+159
+100% +$34K ﹤0.01% 694
2025
Q1 		$35.6K Sell
159
-50
-24% -$13.8K ﹤0.01% 828
2024
Q4 		$68.5K Buy
209
+79
+61% +$24.9K ﹤0.01% 664
2024
Q3 		$39K Sell
130
-126
-49% -$38.6K ﹤0.01% 728
2024
Q2 		$84.3K Sell
256
-4
-2% -$1.41K ﹤0.01% 556
2024
Q1 		$103K Buy
260
+14
+6% +$5.18K ﹤0.01% 472
2023
Q4 		$86.6K Sell
246
-40
-14% -$14.2K ﹤0.01% 493
2023
Q3 		$107K Buy
286
+34
+13% +$13.1K ﹤0.01% 442
2023
Q2 		$96.4K Buy
252
+66
+35% +$23.6K ﹤0.01% 445
2023
Q1 		$64.4K Buy
186
+112
+151% +$32.7K ﹤0.01% 481
2022
Q4 		$17K Buy
74
+3
+4% +$711 ﹤0.01% 675
2022
Q3 		$17K Buy
71
+6
+9% +$1.83K ﹤0.01% 628
2022
Q2 		$20K Buy
65
+20
+44% +$6.51K ﹤0.01% 578
2022
Q1 		$18K Hold
45
– – ﹤0.01% 612
2021
Q4 		$21K Buy
45
+22
+96% +$9.47K ﹤0.01% 600
2021
Q3 		$10K Buy
23
+4
+21% +$1.69K ﹤0.01% 715
2021
Q2 		$7K Buy
19
+15
+375% +$4.96K ﹤0.01% 771
2021
Q1 		$1K Buy
+4
New +$1.15K ﹤0.01% 1061
2020
Q3 		– Sell
-8
Closed -$2K – 824
2020
Q2 		$2K Buy
+8
New +$1.57K ﹤0.01% 668
2019
Q1 		– Sell
-19
Closed -$1.86K – 1005
2018
Q4 		$1.86K Buy
+19
New +$2.06K ﹤0.01% 845
2018
Q3 		– Sell
-33
Closed -$3.28K – 1116
2018
Q2 		$3.28K Buy
+33
New +$3.04K ﹤0.01% 801
2018
Q1 		– Sell
-8
Closed -$789 – 1090
2017
Q4 		$789 Buy
+8
New +$784 ﹤0.01% 844

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MassMutual Private Wealth & Trust's WST Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its West Pharmaceutical (WST) stake by 8.2% in Q2 2026, buying an estimated $7.95K and bringing the position to 342 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

MassMutual Private Wealth & Trust first reported a position in WST in Q4 2017 and has held it in 26 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MassMutual Private Wealth & Trust held 342 shares of West Pharmaceutical worth $123K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 26 West Pharmaceutical shares in Q2 2026, an estimated $7.95K.
  • West Pharmaceutical made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #543 holding.
  • MassMutual Private Wealth & Trust first reported a position in West Pharmaceutical in Q4 2017 and has held it in 26 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.